Literature DB >> 14707027

Developmental control of titin isoform expression and passive stiffness in fetal and neonatal myocardium.

Sunshine Lahmers1, Yiming Wu, Douglas R Call, Siegfried Labeit, Henk Granzier.   

Abstract

Developmental changes in contractile behavior are known to occur during fetal and postnatal heart development. In this study, we examined whether adaptations take place in titin. A range of species was used to evaluate titin isoform expression and altered function during cardiac muscle development. A novel titin exon microarray that allows all 363 titin exons to be monitored simultaneously was used for transcript studies. Results reveal expression of fetal titin isoforms, characterized by additional spring elements both in the tandem Ig and PEVK region of the molecule. At the protein level, the fetal cardiac isoform predominates in fetal and neonatal myocardium and gradually disappears during postnatal development with a time course that varies in different species. Passive myocardium, contrary to previous reports, was found to be less stiff in the neonate than in the adult. This can be explained by the unique spring composition of fetal cardiac titin expressed by the neonate. Changes in titin expression are likely to impact functional transitions and diastolic filling behavior during development of the heart.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14707027     DOI: 10.1161/01.RES.0000115522.52554.86

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  142 in total

1.  Maternal nutrient restriction alters gene expression in the ovine fetal heart.

Authors:  Hyung-Chul Han; Kathleen J Austin; Peter W Nathanielsz; Stephen P Ford; Mark J Nijland; Thomas R Hansen
Journal:  J Physiol       Date:  2004-05-07       Impact factor: 5.182

Review 2.  Mechanical control of tissue and organ development.

Authors:  Tadanori Mammoto; Donald E Ingber
Journal:  Development       Date:  2010-05       Impact factor: 6.868

3.  Hyperphosphorylation of mouse cardiac titin contributes to transverse aortic constriction-induced diastolic dysfunction.

Authors:  Bryan Hudson; Carlos Hidalgo; Chandra Saripalli; Henk Granzier
Journal:  Circ Res       Date:  2011-08-11       Impact factor: 17.367

4.  Calcium sensitivity and the Frank-Starling mechanism of the heart are increased in titin N2B region-deficient mice.

Authors:  Eun-Jeong Lee; Jun Peng; Michael Radke; Michael Gotthardt; Henk L Granzier
Journal:  J Mol Cell Cardiol       Date:  2010-05-23       Impact factor: 5.000

Review 5.  Extracellular Matrix and Regenerative Therapies from the Cardiac Perspective.

Authors:  Arin Dogan; Mahmut Parmaksız; A Eser Elçin; Y Murat Elçin
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

Review 6.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

7.  The zebrafish runzel muscular dystrophy is linked to the titin gene.

Authors:  Leta S Steffen; Jeffrey R Guyon; Emily D Vogel; Melanie H Howell; Yi Zhou; Gerhard J Weber; Leonard I Zon; Louis M Kunkel
Journal:  Dev Biol       Date:  2007-06-23       Impact factor: 3.582

8.  Depletion of zebrafish titin reduces cardiac contractility by disrupting the assembly of Z-discs and A-bands.

Authors:  Michael Seeley; Wei Huang; Zhenyue Chen; William Oscar Wolff; Xueying Lin; Xiaolei Xu
Journal:  Circ Res       Date:  2006-12-14       Impact factor: 17.367

Review 9.  Novex-3, the tiny titin of muscle.

Authors:  Dalma Kellermayer; John E Smith; Henk Granzier
Journal:  Biophys Rev       Date:  2017-04-07

10.  The multifunctional Ca(2+)/calmodulin-dependent protein kinase II delta (CaMKIIδ) phosphorylates cardiac titin's spring elements.

Authors:  Carlos G Hidalgo; Charles S Chung; Chandra Saripalli; Mei Methawasin; Kirk R Hutchinson; George Tsaprailis; Siegfried Labeit; Alicia Mattiazzi; Henk L Granzier
Journal:  J Mol Cell Cardiol       Date:  2012-12-05       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.